Posted on by Speer

WORKSHOPS
FRIDAY, OCTOBER 1, 2021

  815WORKSHOP I

CARDIOPULMONARY TRANSITION, POSTNATAL STABILIZATION
AND EMERGENCIES
Chair: O.D. Saugstad, Oslo, Norway; D. Singer, Hamburg, Germany

• Monitoring stabilization/resuscitation at birth
   A.B. te Pas, Leiden, The Netherlands

• Neonatal resuscitation guidelines: Scientific rationale and evidence
   O.D. Saugstad, Oslo, Norway

• Reversing the irreversible? Interactions between hypoxia and hypothermia in the perinatal period
   D. Singer, Hamburg, Germany

  945Interactive Discussion


1015Coffee Break


1045WORKSHOP II

RDS AND SURFACTANT
Chair: G. Dimitriou, Patras, Greece; H. Verder, Holbaek, Denmark

• Effects of diabetes during pregnancy on the fetus and newborn
   H. Hummler, Tübingen, Germany

• Disease specific strategies of neonatal ventilation
   G. Dimitriou, Patras, Greece

• European guidelines for the management of RDS
   D.G. Sweet, Belfast, Northern Ireland

1215Interactive Discussion


1245Lunch Break


1300Poster Session___

I      RESPIRATORY CARE, PULMONARY DISEASES AND BPD
        Chair: G. Dimitriou, Patras, Greece; J.M. Solano, Bogota, Colombia

II      NUTRITION / GROWTH / NEURODEVELOPMENTAL OUTCOME
         Chair: A. Liubsys, Vilnius, Lithuania; W. W. Hay Jr., Denver, USA


1400WORKSHOP III

OPTIMAL VENTILATORY STRATEGIES
Chair: C. Bührer, Berlin, Germany; C. Wright, Denver, USA

• Ventilatory strategies to prevent lung injury
   E. Bancalari, Miami, USA

• iNo for preterm infants: Evidence versus practice
   B. Thébaud, Ottawa, Canada

• Lung hypoplasia or dry lung syndrome?
   H. Hummler, Tübingen, Germany

1530Interactive Discussion


1600Coffee Break


1630WORKSHOP IV

BPD: FROM BENCH TO BEDSIDE
Chair: S. Andersson, Helsinki, Finland; K. Glaser, Leipzig, Germany

• Experimental models of BPD
   R.E. Morty, Heidelberg, Germany

• Pulmonary hypertension and BPD
   L.J. van Marter, Boston, USA

• Present and future of BPD
   E. Baraldi, Padova, Italy

1800Interactive Discussion


1830Parallel Seminars___

A      How to get your manuscript rejected?
         E.S. Shinwell, Tsfat, Israel

B      How to design a clinical trial: From basics to pitfalls
         N. Modi, London, UK

C      Neonatal clinical pharmacology:
A delA delicate combination of developmental biology and genetics
         J.N. van den Anker, Washington D.C., USA


1915Adjourn


WORKSHOPS
FRIDAY, OCTOBER 1, 2021

Parallel Sessions

  815WORKSHOP V

INTRAUTERINE INFLAMMATION AND INFECTION
Chair: S. Andersson, Helsinki, Finland; W.S. Park, Seoul, Korea

• Antibiotics, animals and antimicrobial resistance
   C. Bührer, Berlin, Germany

• Ureaplasma species: The hidden danger for preterm infants
   K. Glaser, Würzburg, Germany

• Postnatal CMV-infection in very premature infants: Does it matter?
   R. Goelz, Tübingen, Germany

   945Interactive Discussion


1015Coffee Break


1045WORKSHOP VI

THE NEONATAL IMMUNE SYSTEM AND IMMUNODEFICIENCIES
Chair: S. Andersson, Helsinki, Finland; B. Thébaud, Ottawa, Canada

• Modulation of the immune-microbiome interplay - any benefit for the newborn?
   C. Härtel, Würzburg, Germany

• When mother’s antibodies attack the neonate
   C. Bührer, Berlin, Germany

• Rare but dangerous: Immunodeficiencies of the newborn
   H. Morbach, Würzburg, Germany

1215Interactive Discussion


1245Lunch Break


1300Poster Session___

I      RESPIRATORY CARE, PULMONARY DISEASES AND BPD
        Chair: G. Dimitriou, Patras, Greece; J.M. Solano, Bogota, Colombia

II      NUTRITION / GROWTH / NEURODEVELOPMENTAL OUTCOME
        Chair: A. Liubsys, Vilnius, Lithuania; W. W. Hay Jr., Denver, USA


1400WORKSHOP VII

STRATEGIES FOR A SUCCESSFUL FEEDING
Chair: W.W. Hay Jr., Denver, USA; I. Iskander, Cairo, Egypt

• Parenteral nutrition for immature preterm infants in the first week of life and beyond:
Fluid intake, electrolytes and energy supply
   W.W. Hay Jr., Denver, USA

• Do we need fortifiers and nutritional supplements for preterm infants?
   N. Modi, London, UK

• Strategies for a successful feeding of the premature baby
   A. Liubsys, Vilnius, Lithuania

1530Interactive Discussion


1600Coffee Break


1630WORKSHOP VIII

PAIN, SEIZURES AND ROP
Chair: N. Marlow, London, UK; J.M. Solano, Bogota, Colombia

• Is there a way to measure pain perception in preterm infants?
   R. Slater, Oxford, UK

• The role of aEEg in seizure identification and prediction of outcome
   L.S. de Vries, Utrecht, The Netherlands

• Growth factors and Anti-VEGF in severe ROP: Has the time come?
   A. Hellström, Gothenburg, Sweden

 1800Interactive Discussion


1830Parallel Seminars___

A      How to get your manuscript rejected?
         E.S. Shinwell, Tsfat, Israel

B      How to design a clinical trial: From basics to pitfalls
         N. Modi, London, UK

C      Neonatal clinical pharmacology:
A delA delicate combination of developmental biology and genetics
         J.N. van den Anker, Washington D.C., USA


1915Adjourn